Should You Continue to Hold Thermo Fisher Stock in Your Portfolio Now?

Key Takeaways TMO acquired Solventum's unit for $4.1B and Olink to expand biologics and proteomics capabilities. TMO's recent product launches include CorEvitas AA Registry and EVOS S1000 Spatial Imaging System. Thermo Fisher faces ongoing macroeconomic and currency headwinds that may impact profitability.Thermo Fisher Scientific Inc. (TMO) focuses on expanding through the acquisition of technologies and businesses that augment its existing products and services. The company continues to enhance its portf ...